Venture Capital

With its AI-powered blood test nearing FDA review, DELFI Diagnostics adds a top biotech CFO to its board, signaling major commercial and IPO ambitions.

WACKER is set to reveal a cost-saving XRF testing method and a breakthrough gamma-sterilizable medical adhesive, poised to impact two key sectors.

The firm's oversubscribed fund highlights investor confidence in its strategy of backing founder-owned industrial and services companies.

AI marketing firm RAD Amplify hires Tom Costello, a digital ad veteran, to scale its creator intelligence platform among Fortune 1000 brands.

With a $30,000 FedEx grant, AI logistics leader Venti Technologies is poised to accelerate its mission of automating global supply chains.

A Calgary startup's revolutionary wound care gel, already used in hospitals, is now being funded by the government for battlefield trauma applications.

An alumnus's $1M gift lets Rutgers students manage a real portfolio. In a volatile market, their disciplined strategy is already beating Wall Street benchmarks.

Constellation Software's Perseus arm buys Starkwood Media, signaling a major shift toward integrated digital platforms for UK vehicle dealerships.

A landmark partnership aims to solve the AI power crunch by deploying massive floating data centers, turning global shipyards into server farms.

U.S. IT leader Integris announces its intent to acquire First Focus, creating the world's largest SMB-focused MSP and accelerating global AI adoption.

Once a promising EV startup, Bollinger Motors has collapsed. Its complete manufacturing assets and new trucks are now up for auction in a cautionary tale.

With a $47M Series A, Fathom Therapeutics is using quantum physics and AI to simulate protein dynamics, aiming to create drugs for impossible targets.

A new firm led by industry veterans is challenging market research by linking what people say with what they actually do. Here’s how it plans to win.

RedHill Biopharma flips a capital deficit to positive equity, driven by savvy partnerships for its drugs Talicia and Bekinda and a promising R&D pipeline.

With $60M in new funding, Orkes aims to solve the AI 'execution gap,' helping enterprises move AI from pilot to production using its Netflix-proven tech.

Pearson CEO Omar Abbosh's nomination to Autodesk's board signals a strategic push into AI-driven SaaS, reflecting a major industry trend.

Rail constructor Martinus Group launches a new haulage service with Chinese-made locomotives, aiming to disrupt Australia's bulk commodity transport sector.

A new app wants to turn every wedding guest into a photographer, creating a private, real-time album. But can its privacy-first model win a crowded market?

Amidst industry consolidation, XanEdu spins off to refocus on affordable, custom curriculum, signaling a strategic shift toward specialization in education.

NerView Surgical's NerveSense™ wins FACIT's top award, spotlighting a growing ecosystem making Ontario a global leader in oncology innovation.